Stock screenerAll disclosures →
EDGAR →
ANAB
Conviction 64HealthcareScan · Thu, Jun 25, 2026ANAB$59.63+1.97%
ResistanceSupportVol 14Vol MA14 543.53K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price59.63
Change+1.97%
Gap+2.98%
Rel volume1.73×
Avg volume576.7K
Avg $ vol31.86M
SMA 2055.24
SMA 5059.59
SMA 20048.48
Price vs 50+0.07%
Price vs 200+23.01%
MA stackbullish
50/200 cross—
Supertrenddown · 60.67
RSI (14)56
MACD hist0.92
MACD crossbull · 8d
Stoch %K / %D78 / 74
ADX (14)19
+DI / −DI25 / 18
RSI divergence—
MACD divergence—
ATR %+5.37%
ADR %4.89%
52w high70.22
52w low19.40
From 52w high-15.08%
Above 52w low+207.37%
New 52w highNo
SqueezeOff
Bollinger width23.85%
%B0.83
Donchian pos78.06%
Donchian high62.32
Donchian low50.06
AVWAP (52w high)60.07
vs AVWAP high-0.74%
AVWAP (52w low)48.95
vs AVWAP low+21.81%
OBV trendFlat
Chaikin MF (20)-0.18
Today vs 20d1.73×
Avg vol (14d)543.53K
Avg vol (20d)576.7K
Avg $ vol (20d)31.86M
Market cap1.74B
RS 3m (vs SPY)-19.46%
RS 6m (vs SPY)+11.42%
RS line new highNo
Trend template7/8
Technical rank74.1
1 week+5.04%
1 month+3.22%
3 months-8.81%
6 months+18.48%
1 year+155.70%
YTD+32.66%
P/E-131.14
P/B136.13
P/S7.40
P/FCF88.49
EPS-0.4600
Div yield—
ROE-103.80%
ROA-4.01%
Debt/Eq—
Current7.58
EV/EBITDA30.68
Gross margin—
Net margin-5.64%
Rev growth157.01%
EPS growth90.89%
Price target79.86
Target upside33.93%
Analyst ratingBuy
Institutional104.05%
Ent. value1.49B
Revenue25.56M
Net income-52.88M
Gross profit—
Free cash flow19.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out29.1M
Employees104
ListedThu, Jan 26, 2017
Free float17.05M
Float %61.6%
Short interest4.82M
Days to cover9.8d
Short volume76.3%
Squeeze score96 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.22 · 3 est
Last EPS vs est−$1.84 vs −$0.32
Last surprise-475.0% miss
Setup gradeB
Conviction64 / 100
Pattern quality—
Tech rank74.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance71.42
Support50.12
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ANAB
No recent disclosed trades by Congress in ANAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ANAB · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
RENTON HOLLINGS Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
RENTON HOLLINGS Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Orwin John A Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Common Stock · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Schmid John P. Director · Restricted Stock Unit · 2026-06-15 | Exercise | 6.03K | — | 2026-06-15 | 2026-06-17 |
Murphy Christopher M. Chief Financial Officer · Restricted Stock Units · 2026-05-11 | Grant | 25.77K | $0 | 2026-05-11 | 2026-05-13 |
Hughes Owen Director · Restricted Stock Units · 2026-05-11 | Grant | 11.25K | $0 | 2026-05-11 | 2026-05-13 |
GRAY SUSANNAH Director · Restricted Stock Unit · 2026-04-27 | Grant | 11.25K | $0 | 2026-04-27 | 2026-04-29 |
Faga Daniel President, CEO · Employee Stock Option (right to buy) · 2026-04-20 | Disposition | 11K | $0 | 2026-04-20 | 2026-04-23 |
SEC filings
EDGAR filings in ANAB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.